TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway

Ilaria Grazia Zizzari1, Chiara Napoletano2, Andrea Botticelli3

  • 1Laboratory of Tumor Immunology and Cell Therapy, Department of Experimental Medicine, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy. ilaria.zizzari@uniroma1.it.

Insights

Pazopanib, a tyrosine kinase inhibitor, enhances dendritic cell function and T-cell proliferation in metastatic renal cell carcinoma (mRCC) patients. This suggests pazopanib may improve responses when combined with immune checkpoint inhibitors.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Metastatic renal cell carcinoma (mRCC) treatment has improved with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs).
  • Understanding TKI immunomodulatory effects and patient selection is crucial for optimizing immunotherapy in mRCC.

Purpose of the Study:

  • To investigate the impact of the TKI pazopanib on dendritic cell (DC) performance and immune priming in mRCC.
  • To explore the underlying mechanisms of pazopanib's effects on DCs and T-cells.

Main Methods:

  • Assessed DC differentiation, maturation markers (HLA-DR, CD40, CCR7), IL10 production, endocytosis, and T-cell proliferation.
  • Investigated the effect of pazopanib on the Erk/β-catenin pathway and PD-L1 expression.
  • Confirmed findings in DCs from mRCC patients undergoing pazopanib treatment.

Main Results:

  • Pazopanib improved DC differentiation and performance, increasing maturation markers and T-cell proliferation while decreasing IL10 and endocytosis.
  • Pazopanib downregulated PD-L1 expression and inhibited the Erk/β-catenin pathway.
  • Pazopanib enhanced circulating CD4+ T-cells expressing CD137 (4-1BB) in treated mRCC patients.

Conclusions:

  • Pazopanib exhibits immunomodulatory effects that enhance DC activation and T-cell responses.
  • The Erk/β-catenin pathway may mediate pazopanib-induced DC activation.
  • Pazopanib holds potential for combination therapy with ICIs to improve outcomes in mRCC.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.6K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
3.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.1K
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.3K
Other Glycolytic Pathways01:24

Other Glycolytic Pathways

The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...
990